ReviewChirurgie (Heidelberg, Germany)2026
[Robotic-assisted rectal resection in rectal cancer: current evidence : A narrative review].
Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic-assisted resection (RAR) of rectal carcinomas of the middle and lower third is increasing. In Germany RAR is still the exception in an international comparison. The gold standard is a laparoscopic rectal resection. Apart from registry data that could show lower recurrence rates after RAR, currently there is a multicenter, randomized study available showing 3‑year follow-up data. Local recurrence-free survival as well as disease-free survival were significantly improved after RAR. In addition, functional outcomes such as urinary, male and female sexual function scores were improved after RAR as well as defecation. The RAR has now emerged from the shadow of established techniques and has to be regarded as an important and independent factor in multimodal treatment of rectal cancer with respect to improved oncological and functional results.
Indexed as
Identifiers
42095872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.